Radiopharm Theranostics Expands Supply Agreement With TerThera for Terbium-161 Isotope Use in Prostate Cancer tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Radiopharm Theranostics Ltd (ASX:RAD) is celebrating today after findings from its F18-Pivalate brain glioma imaging study were published in a prestigious.
Radiopharm Theranostics Ltd (ASX:RAD) CEO Riccardo Canevari speaks with Proactive after the company completed a positive pre-Investigational New Drug (IND).
Radiopharm Theranostics Ltd (ASX:RAD) has completed a positive pre-Investigational New Drug (IND) meeting with the U.S. Food and Drug Administration (FDA).